相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae
Shuqing Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection
Janice Y. C. Lo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains
Elena N. Ilina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Clusters of circulating Neisseria gonorrhoeae strains and association with antimicrobial resistance in Shanghai
Mingmin Liao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Molecular Epidemiological Identification of Neisseria gonorrhoeae Clonal Clusters with Distinct Susceptibility Profiles Associated with Specific Groups at High Risk of Contracting Human Immunodeficiency Virus and Syphilis
Wing-Wai Wong et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone
Kazuyoshi Osaka et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2008)
Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone
David M. Whiley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone:: Association with genetic polymorphisms in penA, mtrR, porB1b, and ponA
Robert Lindberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae
David M. Whiley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisserza gonorrhoeae
Sho Takahata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Applications of molecular testing in clinical laboratories for the diagnosis and control of gonorrhea
Jobn Tapsall et al.
FUTURE MICROBIOLOGY (2006)
European Surveillance of Sexually Transmitted Infections (ESSTI):: the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe
I. M. C. Martin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype
M Tanaka et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability
SQ Zhao et al.
MOLECULAR MICROBIOLOGY (2005)
Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan
M Ito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area
IMC Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Mosaic-like structure of penicillin-binding protein 2 gene (PenA) in clinical isolates of Neissetia gonorrhoeae with reduced susceptibility to cefixime
S Ameyama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus penC are requiree for hig-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae
PA Ropp et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
